ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/(alphaR,betaS)-rel-beta-(Acetylamino)-alpha-hydroxy-gamma-oxobenzenebutanoic acid
C12H13NO5
251.23 g/mol
Pharmaceutical Intermediate

(2S,3S)-3-acetamido-2-hydroxy-4-oxo-4-phenylbutanoic acid

CAS87081-54-7
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

This compound is a pharmaceutical intermediate used in peptide synthesis. It features an aromatic ring, an amide group, a carboxylic acid, and a secondary alcohol, and is typically supplied as a research reagent for laboratory-scale manufacturing.

Pharmaceutical intermediate for peptide synthesisLaboratory research reagent

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing (2S,3S)-3-acetamido-2-hydroxy-4-oxo-4-phenylbutanoic acid?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

ReferenceSame Category

2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole

CAS871125-67-6

pharmaceutical intermediate

ReferenceSame Category

4-Amino-1-Boc-piperidine

CAS87120-72-7

pharmaceutical intermediate

ReferenceSame Category

Ethyl 3-oxocyclobutanecarboxylate

CAS87121-89-9

pharmaceutical intermediate

ReferenceSame Category

1,2-dilinoleyloxy-3-dimethylaminopropane

CAS871258-12-7

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(2S,3S)-3-acetamido-2-hydroxy-4-oxo-4-phenylbutanoic acid

InChIKey

JRVRHJSMHHKUKE-KOLCDFICSA-N

SMILES

CC(=O)N[C@@H]([C@@H](C(=O)O)O)C(=O)C1=CC=CC=C1

Synonyms (4)

—

Sourcing (2S,3S)-3-acetamido-2-hydroxy-4-oxo-4-phenylbutanoic acid?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→